683 Capital Management’s OncoSec Medical Incorporated ONCS Stock Holding History

683 Capital Management’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,645	Closed	-$801K	–	282
2020 Q4	$801K	Buy	5,645 +2,012	+55%	+$215K	0.04%	125
2020 Q3	$270K	Hold	3,633	–	–	0.02%	116
2020 Q2	$164K	Hold	3,633	–	–	0.01%	124
2020 Q1	$102K	Hold	3,633	–	–	0.01%	125
2019 Q4	$145K	Sell	3,633 -4,912	-57%	-$222K	0.02%	140
2019 Q3	$370K	Hold	8,545	–	–	0.04%	104
2019 Q2	$476K	Buy	8,545 +7,181	+526%	+$691K	0.04%	114
2019 Q1	$167K	Hold	1,364	–	–	0.02%	122
2018 Q4	$192K	Hold	1,364	–	–	0.01%	137
2018 Q3	$420K	Hold	1,364	–	–	0.03%	112
2018 Q2	$414K	Buy	+1,364	New	+$478K	0.03%	113

Other funds holding ONCS

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

683 Capital Management's ONCS Position: Q1 2021 in Review

683 Capital Management sold out of OncoSec Medical Incorporated (ONCS) in Q1 2021, closing a stake of 5,645 shares — an estimated $801K sold.

683 Capital Management first reported a position in ONCS in Q2 2018 and held it in 11 quarters. The position peaked at $801K in Q4 2020. 34 funds tracked by Wall St. Rank hold ONCS as of Q1 2021.

683 Capital Management reported no remaining OncoSec Medical Incorporated position as of Q1 2021 after selling out during the quarter.
683 Capital Management sold 5,645 OncoSec Medical Incorporated shares in Q1 2021, an estimated $801K.
683 Capital Management first reported a position in OncoSec Medical Incorporated in Q2 2018 and held it in 11 quarters.
683 Capital Management's OncoSec Medical Incorporated position peaked at $801K in Q4 2020.
34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2021.

Based on 683 Capital Management's 13F filing for Q1 2021, filed 17 May 2021.